查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609026

代谢体学市场：按产品/服务、适应症、应用、最终用户划分 - 2025-2030 年全球预测

Metabolomics Market by Product & Service (Bioinformatics Tools & Services, Metabolomics Instruments), Indication (Cancer, Cardiovascular Disorders, Inborn Errors of Metabolism), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年代谢体学市值为37.4亿美元，预计到2024年将达到42.8亿美元，复合年增长率为15.06%，到2030年将达到99.9亿美元。

代谢体学是生物样本内代谢物的综合研究，是理解生物体复杂的生化过程的重要工具。该领域对于个人化医疗、疾病生物标记发现和系统生物学的进步至关重要。其应用领域广泛，包括製药、生物技术、农业基因组学、食品和饮料等，使其成为健康和营养创新的重要资产。影响调查方法发展的关键因素包括分析方法的技术进步、製药和生物技术研发投资的增加以及需要增强诊断方法的慢性病盛行率的上升。质谱和核磁共振的最新技术创新，加上生物资讯学的进步，为早期疾病检测和精准医学的发展提供了重要机会。然而，设备高成本和对熟练人员的需求等挑战可能会阻碍市场成长。也迫切需要方法和资料解释的标准化，以弥合复杂资料输出和实际应用之间的差距。儘管有这些担忧，北美和欧洲等地区由于其支持性法律规范和高医疗保健支出，在代谢体学创新方面仍处于领先地位。为了利用这个不断成长的市场，企业应专注于扩大学术机构和产业相关人员之间的合作网络，以促进技术开发和知识交流。此外，开发具有成本效益的高通量筛检方法有可能改变各行业代谢物分析的可及性和应用。微生物代谢体学、植物代谢体学和环境代谢体学等新领域的探索有可能带来新产品的开发和多样化。代谢体学市场不断发展的性质为研究和创新提供了肥沃的土壤，公司正在利用技术进步，您需要紧跟政策变化。

主要市场统计
基准年[2023] 37.4亿美元
预计年份 [2024] 42.8亿美元
预测年份 [2030] 99.9亿美元
复合年增长率（%） 15.06%

市场动态：揭示快速发展的代谢体学市场的关键市场洞察

供给和需求的动态交互作用正在改变代谢体学市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 癌症患者数量的增加和对先进治疗的需求
    • 继续推出个人化医疗
    • 政府积极进行相关研究工作
  • 市场限制因素
    • 对复杂资料监控和资料的担忧
  • 市场机会
    • 代谢体学市场参与企业新技术的出现
    • 单细胞代谢体学的兴起
  • 市场挑战
    • 全球医疗保健领域缺乏熟练的专业人员

波特的五力：驾驭代谢代谢体学市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解代谢体学市场的外部影响

外部宏观环境因素在塑造代谢体学市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解代谢体学市场的竞争格局

代谢体学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵代谢体学市场供应商绩效评估

FPNV定位矩阵是评估代谢体学市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了代谢体学市场的成功之路

代谢体学市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症病例的盛行率和先进治疗的需要
      • 继续推出个人化医疗
      • 与代谢体学研究相关的首选政府倡议
    • 抑制因素
      • 对复杂资料监控和资料的担忧
    • 机会
      • 代谢体学市场参与者与新技术的出现
      • 单细胞代谢体学的兴起
    • 任务
      • 全球医疗保健领域缺乏熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章代谢体学市场：依产品与服务

  • 生物资讯学工具和服务
    • 生物资讯服务
    • 生物资讯工具和资料库
  • 代谢体学仪器
    • 检测工具
      • 质谱分析
      • 核磁共振波谱
      • 基于表面的质谱分析
    • 分离工具
      • 毛细管电泳
      • 气相层析法
      • 高效液相层析
      • 超高效液相层析

第七章依适应症分類的代谢体学市场

  • 癌症
  • 心血管疾病
  • 先天性代谢异常
  • 代谢紊乱
  • 神经系统疾病

第八章代谢体学市场：依应用分类

  • 生物标记发现
  • 药物发现
  • 功能基因体学
  • 营养基因体学
  • 个人化医疗
  • 毒性试验

第 9 章代谢体学市场：依最终使用者划分

  • 学术研究所
  • 合约调查机构
  • 製药和生物技术公司

第10章美洲代谢体学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区代谢体学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的代谢体学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Afekta Technologies Ltd.
  • Bio-Rad Laboratories, Inc.
  • Biocrates Life Science AG
  • Bruker Corporation
  • Danaher Corporation
  • General Electric Company
  • Hitachi High-Tech Corporation
  • Human Metabolome Technologies America Inc.
  • Japan Spectroscopic Company
  • Kore Technology Limited
  • LECO Corporation
  • Merck KGaA
  • SCION Instruments UK Ltd
  • Shimadzu Corporation
  • Waters Corporation
Product Code: MRR-50124643847C

The Metabolomics Market was valued at USD 3.74 billion in 2023, expected to reach USD 4.28 billion in 2024, and is projected to grow at a CAGR of 15.06%, to USD 9.99 billion by 2030.

Metabolomics, a comprehensive study of metabolites within a biological specimen, serves as a pivotal tool in understanding the intricate biochemical processes of living organisms. This field is critical for advancements in personalized medicine, disease biomarker discovery, and systems biology. Its application spans pharmaceuticals, biotechnology, agrigenomics, and food & beverages, among other sectors, making it an indispensable asset for innovation in health and nutrition. Key factors influencing the metabolomics market's growth include technological advancements in analytical techniques, increasing pharmaceutical and biotech R&D investments, and the rising prevalence of chronic diseases necessitating enhanced diagnostic methodologies. Recent technological innovations in mass spectrometry and nuclear magnetic resonance, coupled with advancements in bioinformatics, present significant opportunities for early disease detection and precision medicine development. However, challenges such as high costs of instruments and the need for skilled personnel may hinder market growth. There is also a notable requirement for standardization in methodologies and data interpretation to bridge the gap between complex data outputs and practical applications. Despite these concerns, regions like North America and Europe are leading metabolomics innovations due to supportive regulatory frameworks and substantial healthcare spending. To capitalize on this growing market, businesses should focus on expanding collaborative networks between academic institutions and industry players to spur technological development and knowledge exchange. Additionally, the development of cost-effective, high-throughput screening methods could transform metabolite analysis accessibility and application in various industries. Exploring novel areas such as microbiome metabolomics, plant metabolomics, and environmental metabolomics holds promise for new product development and diversification. The ever-evolving nature of the metabolomics market suggests a fertile ground for research and innovation, necessitating organizations to stay abreast of technological advancements and policy changes to optimize their strategy for sustained growth and competitive advantage.

KEY MARKET STATISTICS
Base Year [2023] USD 3.74 billion
Estimated Year [2024] USD 4.28 billion
Forecast Year [2030] USD 9.99 billion
CAGR (%) 15.06%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Metabolomics Market

The Metabolomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of cancer cases and need for advanced therapies
    • Ongoing adoption of personalized medicines
    • Favorable governmental initiatives associated with metabolomics research
  • Market Restraints
    • Concern regarding the complex data monitoring and data processing
  • Market Opportunities
    • Emergence of novel technologies along with market players for metabolomics
    • Rise of single-cell metabolomics
  • Market Challenges
    • Scarcity of skilled professionals in the healthcare sectors worldwide

Porter's Five Forces: A Strategic Tool for Navigating the Metabolomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Metabolomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Metabolomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Metabolomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Metabolomics Market

A detailed market share analysis in the Metabolomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Metabolomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Metabolomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Metabolomics Market

A strategic analysis of the Metabolomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Metabolomics Market, highlighting leading vendors and their innovative profiles. These include Afekta Technologies Ltd., Bio-Rad Laboratories, Inc., Biocrates Life Science AG, Bruker Corporation, Danaher Corporation, General Electric Company, Hitachi High-Tech Corporation, Human Metabolome Technologies America Inc., Japan Spectroscopic Company, Kore Technology Limited, LECO Corporation, Merck KGaA, SCION Instruments UK Ltd, Shimadzu Corporation, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Metabolomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Bioinformatics Tools & Services and Metabolomics Instruments. The Bioinformatics Tools & Services is further studied across Bioinformatics Services and Bioinformatics Tools & Databases. The Metabolomics Instruments is further studied across Detection Tools and Separation Tools. The Detection Tools is further studied across Mass Spectrometry, Nuclear Magnetic Resonance Spectroscopy, and Surface-Based Mass Analysis. The Separation Tools is further studied across Capillary Electrophoresis, Gas Chromatography, High-performance Liquid Chromatography, and Ultra-performance Liquid Chromatography.
  • Based on Indication, market is studied across Cancer, Cardiovascular Disorders, Inborn Errors of Metabolism, Metabolic Disorders, and Neurological Disorders.
  • Based on Application, market is studied across Biomarker discovery, Drug discovery, Functional Genomics, Nutrigenomics, Personalized medicine, and Toxicology testing.
  • Based on End User, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cancer cases and need for advanced therapies
      • 5.1.1.2. Ongoing adoption of personalized medicines
      • 5.1.1.3. Favorable governmental initiatives associated with metabolomics research
    • 5.1.2. Restraints
      • 5.1.2.1. Concern regarding the complex data monitoring and data processing
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of novel technologies along with market players for metabolomics
      • 5.1.3.2. Rise of single-cell metabolomics
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of skilled professionals in the healthcare sectors worldwide
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Metabolomics Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Bioinformatics Tools & Services
    • 6.2.1. Bioinformatics Services
    • 6.2.2. Bioinformatics Tools & Databases
  • 6.3. Metabolomics Instruments
    • 6.3.1. Detection Tools
      • 6.3.1.1. Mass Spectrometry
      • 6.3.1.2. Nuclear Magnetic Resonance Spectroscopy
      • 6.3.1.3. Surface-Based Mass Analysis
    • 6.3.2. Separation Tools
      • 6.3.2.1. Capillary Electrophoresis
      • 6.3.2.2. Gas Chromatography
      • 6.3.2.3. High-performance Liquid Chromatography
      • 6.3.2.4. Ultra-performance Liquid Chromatography

7. Metabolomics Market, by Indication

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Cardiovascular Disorders
  • 7.4. Inborn Errors of Metabolism
  • 7.5. Metabolic Disorders
  • 7.6. Neurological Disorders

8. Metabolomics Market, by Application

  • 8.1. Introduction
  • 8.2. Biomarker discovery
  • 8.3. Drug discovery
  • 8.4. Functional Genomics
  • 8.5. Nutrigenomics
  • 8.6. Personalized medicine
  • 8.7. Toxicology testing

9. Metabolomics Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Metabolomics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Metabolomics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Metabolomics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Afekta Technologies Ltd.
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Biocrates Life Science AG
  • 4. Bruker Corporation
  • 5. Danaher Corporation
  • 6. General Electric Company
  • 7. Hitachi High-Tech Corporation
  • 8. Human Metabolome Technologies America Inc.
  • 9. Japan Spectroscopic Company
  • 10. Kore Technology Limited
  • 11. LECO Corporation
  • 12. Merck KGaA
  • 13. SCION Instruments UK Ltd
  • 14. Shimadzu Corporation
  • 15. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. METABOLOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. METABOLOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL METABOLOMICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL METABOLOMICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. METABOLOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. METABOLOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. METABOLOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL METABOLOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL METABOLOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. METABOLOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & DATABASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL METABOLOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL METABOLOMICS MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL METABOLOMICS MARKET SIZE, BY SURFACE-BASED MASS ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL METABOLOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL METABOLOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL METABOLOMICS MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL METABOLOMICS MARKET SIZE, BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL METABOLOMICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL METABOLOMICS MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL METABOLOMICS MARKET SIZE, BY INBORN ERRORS OF METABOLISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL METABOLOMICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL METABOLOMICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL METABOLOMICS MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL METABOLOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL METABOLOMICS MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL METABOLOMICS MARKET SIZE, BY NUTRIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL METABOLOMICS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL METABOLOMICS MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL METABOLOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL METABOLOMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL METABOLOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES METABOLOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA METABOLOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 348. SWITZERLAND METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND METABOLOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY METABOLOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY METABOLOMICS MARKET SIZE, BY METABOLOMICS INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY METABOLOMICS MARKET SIZE, BY DETECTION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY METABOLOMICS MARKET SIZE, BY SEPARATION TOOLS, 2018-2030 (USD MILLION)
  • TABLE 355. TURKEY METABOLOMICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 356. TURKEY METABOLOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)

T